Celularity Inc Sustainability Reports
Celularity Inc. is a clinical-stage biotechnology and cellular medicine company that develops and manufactures allogeneic cell therapies derived from the postpartum human placenta.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
3 reports from 2022 to 2024
Company Profile
Celularity Inc. is a clinical-stage biotechnology and cellular medicine company that develops and manufactures allogeneic cell therapies derived from the postpartum human placenta.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
